thiophenes has been researched along with acenocoumarol in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arche, GJ; Drouin, B; Grand, A | 1 |
| Goebel, N; Krayenbühl, HP; Pfluger, N; Rothlin, ME; Senning, A; Speiser, K; Steinbrunn, W; Turina, M | 1 |
| Camarda, C; Camarda, R; Monastero, R | 1 |
| Ferrandis, R; Llau, JV; López Forte, C; Sapena, ML | 1 |
| Gutiérrez, R; Lupi, E; Miranda, MT; Peña, H; Pulido, T; Roquet, I; Rueda, T; Sandoval, J; Santos, E | 1 |
| Agnelli, G; Bauersachs, R; Berkowitz, SD; Bounameaux, H; Brenner, B; Buller, HR; Cohen, A; Davidson, BL; Decousus, H; Gallus, AS; Lensing, AW; Misselwitz, F; Piovella, F; Prins, MH; Raskob, GE; Schellong, S; Segers, A; Verhamme, P; Wells, P | 1 |
| Valle Bernad, R | 1 |
| Blanco-Molina, A | 1 |
| Bonnabry, P; Daali, Y; Dayer, P; Desmeules, JA; Gschwind, L; Rollason, V | 1 |
1 review(s) available for thiophenes and acenocoumarol
| Article | Year |
|---|---|
[Anaesthesia and thromboembolic disease].
Topics: Acenocoumarol; Administration, Oral; Anesthesia, Conduction; Anticoagulants; Benzimidazoles; Clinical Protocols; Dabigatran; Early Ambulation; Fibrinolytic Agents; Fondaparinux; Heparin; Heparin, Low-Molecular-Weight; Humans; Morpholines; Polysaccharides; Postoperative Complications; Pyridines; Risk Factors; Rivaroxaban; Safety; Surgical Procedures, Operative; Thiophenes; Venous Thromboembolism; Venous Thrombosis | 2008 |
3 trial(s) available for thiophenes and acenocoumarol
| Article | Year |
|---|---|
Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion.
Topics: Acenocoumarol; Anticoagulants; Clinical Trials as Topic; Coronary Angiography; Coronary Artery Bypass; Coronary Disease; Graft Occlusion, Vascular; Humans; Middle Aged; Postoperative Complications; Thiophenes; Ticlopidine | 1985 |
Interaction of acenocoumarol and sitaxentan in pulmonary arterial hypertension.
Topics: Acenocoumarol; Adolescent; Adult; Anticoagulants; Antihypertensive Agents; Drug Administration Schedule; Drug Interactions; Endothelin Receptor Antagonists; Female; Hemorrhage; Humans; Hypertension, Pulmonary; International Normalized Ratio; Isoxazoles; Male; Prospective Studies; Survival Analysis; Thiophenes; Young Adult | 2009 |
Oral rivaroxaban for symptomatic venous thromboembolism.
Topics: Acenocoumarol; Acute Disease; Administration, Oral; Aged; Anticoagulants; Double-Blind Method; Enoxaparin; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Injections, Subcutaneous; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Morpholines; Pulmonary Embolism; Rivaroxaban; Thiophenes; Venous Thromboembolism; Venous Thrombosis; Vitamin K; Warfarin | 2010 |
5 other study(ies) available for thiophenes and acenocoumarol
| Article | Year |
|---|---|
[Potentialization of the anticoagulant action of antivitamin K by thienylic acid].
Topics: Acenocoumarol; Aged; Drug Synergism; Gastrointestinal Hemorrhage; Glycolates; Hemorrhage; Humans; Male; Phenoxyacetates; Thiophenes | 1977 |
Potential drug-drug interaction between duloxetine and acenocoumarol in a patient with Alzheimer's disease.
Topics: Acenocoumarol; Alzheimer Disease; Anticoagulants; Drug Interactions; Duloxetine Hydrochloride; Female; Humans; International Normalized Ratio; Middle Aged; Selective Serotonin Reuptake Inhibitors; Thiophenes | 2007 |
[Introduction].
Topics: Acenocoumarol; Anticoagulants; Benzamides; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thromboembolism; Thrombosis; Warfarin | 2012 |
[New advances in anticoagulation: is it time to forget about heparin and vitamin K antagonists? Yes].
Topics: Acenocoumarol; Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Heparin; Humans; Morpholines; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome; Venous Thromboembolism; Warfarin | 2012 |
Role of P-glycoprotein in the uptake/efflux transport of oral vitamin K antagonists and rivaroxaban through the Caco-2 cell model.
Topics: Acenocoumarol; Anticoagulants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Humans; Microscopy, Electron, Transmission; Morpholines; Rivaroxaban; Thiophenes; Vitamin K; Warfarin | 2013 |